InsiderClue
Insiders · Profile

Versant Venture Capital IV, L.P.

10% owner at CRISPR Therapeutics. Filing since 23 Apr 2018. CIK 0001456590

Company
Date
Role
Action
Shares
Amount
Of holding
CRSP CRISPR Therapeutics AG
23 Apr 2018
10% owner
Sold, plan not stated
101,994
$5.17M
69.3%
1 decision on file.